Pharmaceuticals

Global Insights: Alexipharmic Drugs Market Expected to Surpass $7.18 Billion by 2029

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Is the Estimated Industry Valuation for the Alexipharmic Drugs Sector?#_x000D_

The rapid-dissolve tablet industry has seen robust growth in recent years. The market value is expected to rise from $4.96 billion in 2024 to $5.33 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.5%. Factors such as an increase in the elderly population, a surge in chronic diseases, the trend of self-medication, the growth of the pharmaceutical industry, and higher disposable income have contributed to the historic growth._x000D_

_x000D_

In the coming years, the market size for fast melt tablets is anticipated to witness robust growth. It is forecasted to reach “$7.18 billion in 20229, expanding at a compound annual growth rate (CAGR) of 7.7%. This growth over the forecast period is caused by several factors such as increased incidences of dysphagia, rising preferences for OTC medications, enhanced e-commerce involvement, increasing demand for orally dissolving medications, and an increase in healthcare infrastructure. Key trends for the forecast period are technological advancements, novel formulation methods, the use of nanotechnology, a shift towards plant-based excipients, and intelligent drug delivery systems._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp_x000D_

_x000D_

#What Forces Are Driving The Growth Of The Alexipharmic Drugs Market?#_x000D_

The upward trend in fatalities resulting from drug overdosages is anticipated to drive the expansion of the alexipharmic drugs market. A drug overdose typifies the ingestion of a substance exceeding the body’s capacity to handle it, frequently leading to harmful consequences or death. The death toll from drug overdoses incorporates factors such as access to lethal substances, socioeconomic divides, mental health problems, and insufficient availability of addiction therapy and harm reduction services. Alexipharmic drugs play a vital part in reducing death rates by neutralizing the toxic impacts of drugs in overdose situations, thus averting or lessening deaths. For example, data from the Office for National Statistics for December 2023 showed that in England and Wales, there were 4,907 deaths from drug poisoning in 2022, a rise from 4,859 in 2021. Almost half of these were linked to opiates (46.1%; 2,261 deaths), while deaths associated with cocaine increased by 2.0% to 857, indicating a sequential yearly rise. Consequently, the increase in fatalities due to drug overdoses is boosting the alexipharmic drugs market._x000D_

_x000D_

The fast melt tablets market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types _x000D_

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications_x000D_

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable_x000D_

4) By Age Group: Adult, Pediatrics, Geriatrics_x000D_

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

_x000D_

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics _x000D_

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors _x000D_

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives _x000D_

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines _x000D_

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics _x000D_

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics _x000D_

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors _x000D_

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids _x000D_

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole _x000D_

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics_x000D_

_x000D_

#What Trends Are Currently Influencing Growth In The Alexipharmic Drugs Market?#_x000D_

Major players in the fast melt tablets market are striving to innovate by producing products like rapidly dissolving tablets for improved patient comfort and quicker drug absorption. Rapidly dissolving tablets (RDTs) are solid dosages engineered to quickly dissolve in the mouth without requiring water. For example, in December 2022, Melt Pharmaceuticals, a clinical-stage pharmaceutical firm based in the US, introduced Melt 300, an advanced fast-melting tablet formulation aimed at efficient sedation. This ground-breaking sublingual fast-melting tablet, which combines midazolam (3 mg) and ketamine (50 mg), dissolves rapidly, ensuring swift onset and potent sedation without intravenous administration. Melt 300, which caters to the climbing demand for patient-friendly, needle-free sedation alternatives, enhances procedural ease while improving clinical procedures._x000D_

_x000D_

#Which Companies Currently Dominate The Competitive Landscape In The Alexipharmic Drugs Industry?#_x000D_

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc. _x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report_x000D_

_x000D_

#Which Geographic Regions Are Driving Demand In The Alexipharmic Drugs Market?#_x000D_

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_